Register entry

Sebela Pharmaceuticals Inc.

Registered sites
0
Drug products
12
Live patents
1
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Exclusivity

Patents

1

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
ONMELITRACONAZOLEOct 2028
Catalogue

Marketed products

12

Showing 12 of 12.

BrandGeneric nameFormCategory
Analpram HChydrocortisone acetate and pramoxine hydrochlorideCREAMUNAPPROVED DRUG OTHER
Analpram HChydrocortisone acetate and pramoxine hydrochlorideLOTIONANDA
IMURANazathioprineTABLETNDA
LOTRONEXalosetron hydrochlorideTABLETNDA
LOTRONEXalosetron hydrochlorideTABLETNDA
Motofendifenoxin and atropine sulfateTABLETNDA
NaftinNaftifine HydrochlorideGELNDA
Pramosonehydrocortisone acetate and pramoxine hydrochlorideLOTIONANDA
Pramosonehydrocortisone acetate and pramoxine hydrochlorideLOTIONANDA
Pramosonehydrocortisone acetate and pramoxine hydrochlorideOINTMENTUNAPPROVED DRUG OTHER
Pramosonehydrocortisone acetate and pramoxine hydrochlorideOINTMENTUNAPPROVED DRUG OTHER
RIDAURAauranofinCAPSULENDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.